CD34 is expressed on the surface of hematopoietic stem/ progentior cells, stromal cells, and on the surface of highendothelial venules (HEV). CD34 binds L-selectin, an adhesion molecule important for leukocyte rolling on venules and lymphocyte homing to peripheral lymph nodes IPLN). We generated CD34-deficient mutant animals through the use of homologous recombination. Wild-type and mutant animals showed no differences in lymphocyte binding t o PLN HEV, in leukocyte rolling on venules or homing t o PLN, in neutrophil extravasation into peritoneum in response t o inflammatory stimulus, nor in delayed type hypersensitivity. Anti-L-selectin monoclonal antibody (MEL-14) also inhibited these immune responses similarly in both CD34-deficient and wildtype mice. However, eosinophil accumulation in the lung after inhalation of a model allergen, ovalbumin, is several-D34 MONOCLONAL antibodies (MoAbs)" were first C generated against a human primitive lymphoidmyeloid cell. The 1% to 3% of normal bone marrow (BM) cells that express CD34 have been shown to include virtually all unipotent (BFU-F, CFU-GM, CFU-Meg) and multipotent hematopoietic progenitors (CFU-GEMM) and their precursor cells, including precursors of T-and B-lymphoid line a g e~.~ However, CD34 is not expressed by morphologically mature lympho-hematopoietic cells and has therefore been useful as a marker for purifying stem cells for hematopoietic reconstitution in baboons' and humans: and for the manipu- 0006-4971/96/8709-0063$3.00/0 fold lower in mutant mice. We found no abnormalities in hematopoiesis in adult mice and interactions between mutant progenitor cells and a stromal cell line in vitro were normal. No differences existed in the recovery of progenitor cells after 5-fluorouracil treatment, nor in the mobilization of progenitor cells after granulocyte colony-stimulating factor treatment compared with wild-type animals. Surprisingly, although CD34 was not expressed in these mice, a portion of its 90-kD band crossreactive with MECA79 remained after Western blot. Thus, we have identified an additional molecule(~) that might be involved in leukocyte trafficking. These results indicate that CD34 plays an important role in eosinophil trafficking into the lung.
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lation of BM stem cells for gene transfection.' CD34 is also found on stromal cells of the BMR and vascular endothelium. 4 The amino acid sequence for CD34 was predicted from human CD34 cDNA to be a type I integral membrane protein, demonstrating no sequence homology to any other known protein.' Murine CD34 cDNA was cloned by cross-hybridization using a mouse BM cDNA library.'" The coding sequences of murine CD34 are highly similar to humans, and mouse CD34 polyclonal and MoAbs recently have been generated: ''J' The expression pattern and the ability to purify CD34' stem cells are also similar between mice and humans. Although the function of CD34 is poorly defined, data so far suggest that it may play a role in adhesion and signal transduction on cells of the immune system, and that it may have important functions in early hematopoiesis." I 6 Very recently it was reported that the transfection of full-length of CD34 inhibited the cell differentiation of the hematopoietic progenitor M1 cells."
Recruitment and extravasation of leukocytes from the vasculature into tissues is critical for host response to tissue injury, ie, infection, and when defective results in pathophysiology observed in many inflammatory diseases. The recruitment process is regulated, in part, by expression on leukocytes of the selectin family of adhesion molecules, which mediate initial interactions with endothelial cells that results in leukocyte rolling."." L-selectin (CD62L) is one such family member expressed on leukocytes (identified in mice by the MEL-14 MoAb), where it acts as a homing receptor that mediates binding to peripheral lymph nodes (PLNs)*" at high endothelial venules (HEV). Studies in L-selectin-deficient mice have shown that lymphocyte adhesion to PLN HEV is decreased and that trafficking of lymphocytes to PLN is reduced while neutrophil trafficking to acute inflammatory sites and delayed type hypersensitivity (DTH) responses are defective. ' ' . " For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From CD3CDEFICIENT MICE 3551 rine PLN organ culture, the three glycoprotein species sgp50, sgp90, and 200 kD were
The sgp50 L-selectin ligand, cloned and designated GlyCAM-1 , 24 was reported to be a soluble antagonist for L-selectin-dependent adhesion,z3.25 although increased L-selectin-dependent trafficking to draining lymph nodes during immune responses has been shown to coincide with large decreases in GlyCAM-1 expression,26 and thus GlyCAM-1 does not appear to be a major L-selectin counterpart on HEV. Partial amino acid sequencing of sgp90 identified it as the sialomucin CD34,z7 which by use of a rabbit polyclonal antibody to CD34 was shown to be expressed on the HEV of PLN as well as other blood vessel^.^ More recent in vivo labeling studies have identified a 200-kD glycoprotein species in PLN that binds to L-selectin." In another approach, the MECA-79 MoAb was raised against HEV and was subsequently proven to selectively stain HEV in adult peripheral and mesentric lymphnodes.28 This MoAb blocked both the adhesion of lymphocytes to PLN HEV and the trafficking of lymphocytes to PLN, and it has been shown to recognize sulfate-carbohydrate structures expressed on a number of glycoprotein species comprising L-selectin ligands of HEV2*" including 50-kD (GlyCAM-l), 90-kD (CD34), 200-kD glycoproteinsz9 and also other glycoprotein species less heavily labeled by sulfate. However, the relative importance of each of the glycoprotein species is unknown because methods to examine their individual roles in vivo, such as blocking MoAb, have been unavailable. L-selectin is also expressed on the surface of eosinophils, where it takes part in the attachment to endothelial cells. However, although the L-selectin MoAb LAM1-11 selectively inhibits attachment of eosinophils it has little effects on neutrophils, suggesting different functional epitopes exist for L-selectin on eosinophils and neutrophil^.^' The major counterpart for L-selectin on eosinophils is still unknown. Eosinophil accumulation has been observed after inhalation of ovalubumin (OVA) and has been found to involve CD4 T cells.3' Interleukin-5 (IL-5);' RANTES,33 E~t a x i n ,~~ macrophage inflammatory protein-la (MIP-la)," leukotriene B4 (LTB4),36 and platelet activating factor (PAFY7 are reported to be chemoattractic factors (chemokines) that evoke eosinophil migration.
The function of CD34 is of basic interest both to the fields of hematology and immunology. We have investigated the role of CD34 in hematopoiesis and leukocyte trafficking by observing these systems in CD34-deficient mice.
MATERIALS AND METHODS
Construction of targeting vector. Genomic DNA of CD34" exon 8 derived from 129/ola mouse was amplified by polymerase chain reaction (PCR) using the sense primer 5'-CCTCGAGATTAC-ACGGAGAATGGTGGAGGC and antisense primer 5'-CGGTAC-CCAGACATTCAGGAACAGGTGAAC-3'. The 721 bp of Xho I and Kpn I fragment of this PCR product was cloned into Bluescript KS+ cleaved with Xho I and Kpn I to create plasmid pBKSTI. The 1.1-kh BamHI-Xho I fragment of pMClneoPolA (the EamHI site was filled)" and the 3.2-kb EamHI-BamHI fragment containing exons 5-7 of the CD34 gene were ligated to pBKSTI cleaved with EamHI and Xho I. The resulting targeting vector was designnated as pTIneo3.2, containing 3.2 kb of 5' end and 0.7 kb of 3' end homology with the endogenous CD34 gene, and the neo' gene in the antisense transcriptional orientation.
E14 cells from 129/ola were maintained in Dulbecco's modified minimum medium (DMEM) supplemented with 15% fetal calf serum (FCS; GIBCO, Grand Island, NY). 2-Mercaptoethanol (2ME), 5 X 10' m o a , 2 m m o a L-glutamine, and leukemia inhibitory factor (E14 medium) and were subcultured every 2 days after complete trypsinization. Electroporation of ES cells and selection of G41gR colonies were performed as described." For PCR screening, medium was gently replaced with calcium-free, magnesium-free phosphate-buffered saline (PBS-/-), and each C1418~ colony was picked up with a 20 pL micropipette tip under microscopy and transfered to round-hottomed 96-well plates (Nunc, Naperville, IL) filled with 60 pL of PBS-I-per well. After transfer, 30 pL of 0.05% trypsin, 0.53 mmol/L EDTA (GIBCO) was added, followed by incubation for IO minutes in a 37°C 5% C 0 2 incubator. Half aliquots of the resulting single-cell suspension were again transferred to 96-well plates, each well containing 130 pL of E14 medium, and left in a 37°C C 0 2 incubator overnight; on the following day, the medium was replaced with 200 pL of E14 medium for further culture. Remaining cells in the 96-well plates were divided into half aliquots to duplicate 96-well plates for selection by PCR. Two PCR primers were used for identifying CD34 homologous recombination: (1 ) the antisence oligonucleotide 5'-CACTGTCCTGTCTAGGTTGAACC-3' and; (2) neor antisense oligonucleotide 5'-AGAACCTGCGTGCAATCC-ATC-3'. PCR conditions were 40 cycles of 94°C for 1 minute, 62°C for I minute, and 72°C for 1 minute 30 seconds. PCR-positive clones were subsequently confirmed by genomic Southern hybridization. Positive colonies were stored in liquid nitrogen and thawed at least 3 days before blastocyst injection.
Generation of mutant mice. Generation of mutant mice from CD34-targeted ES cells were performed as previously d e~c r i b e d .~.~' C57BL/6J blastocysts were isolated at day 3.5 postcoitum, injected with about 20 mutant ES cells, and transferred to the uteri of CDl pseudopregnant recipient mice at day 2.5 postcoitum. Newbom pups were identified as chimeric on the basis of dark white and/or agouti coat color and bred at 4 weeks of age with C57BL/6J mice. Germline transmission was scored on the basis of agouti coat color of FI pups 2 weeks after birth. Mutant gene transmission was confirmed by genomic Southem blotting of mouse-tail DNA. The mice used in each experiment were 7 to I O weeks old and were obtained by breeding heterozygote pairs.
Flow cytometric analysis. Cells derived from BM were singly suspended, and 1 X IO6 cells were stained on ice with MoAbs for 30 minutes in 100 pL of PBS-I-containing 3% FCS and 0.1% sodium azide, washed with PBS, and analyzed by FACScan (Becton Dickinson, San Jose, CA) using Lysis I1 program (Becton Dickinson). Most of the MoAbs used were purchased commercially (Pharmingen, San Diego, CA). The antimouse-CD34 polyclonal antibody (1 202) has been previously described." Immunohistochemistry. Immunohistochemistry was performed as previously described." Briefly, frozen sections of PLNs were acetone fixed and incubated with purified MoAb in PBS, washed, and treated with a solution of PBS containing a 1:40 dilution of horseradish peroxidase (HRP)-conjugated rabbit-antirat IgG (Dakopatts, Copenhagen, Denmark: this reagent also reacts with rat IgM) and 5% normal mouse serum (NMS). The HRP-conjugated second antibody was detected after exposure to a solution of 0.05 m o w Tris (pH 7.6) containing 0.05% diaminbenzidine and 0.009% H202 (wtlvol) and the staining was enhanced by incubation in 0.5% copper sulfate in saline. Hematoxylin was used to light counterstain the section. 0Z-42,'"a an antibody that binds a determinant expressed in developing mouse brain, was generously supplied by L. Pickford and R. Rouse. CD34 MoAb (RAM34) was commercially purchased from Pharmingen.
Transfection and selection of mutant ES cells.
For personal use only. To identify the components of the 90-kD band HEV lysate was passed through agarose columns crosslinked with either CD34 MoAb (RAM34). CD45 MoAb (30G12), L-selectin MoAb (MEL-14), or normal rat serum. Eluent was run on SDS-PAGE next to material eluted from columns.
Lymphocyte binding to HEV was assessed as described?' In brief, single-cell suspensions of mouse splenocytes were isolated by density gradient centrifusion on FicollPaque (Pharmacia LKB, Uppsala, Sweden). Isolated cells were washed three times with RPMI 1640 medium containing 5% FCS and IO mmoVL HEPES, resuspended at 2.5 x lo4 cells/mL, and kept at 4°C. The lymphocytes (200 pL) from control mouse (C57BLI 6J) were overlaid onto 12-pm frozen sections of +/+ and -/-mice PLN mounted on glass slides. The lymph nodes from freshly euthanized mouse were snap frozen in isopentanefiiquid nitrogen and stored at -70°C in isopentane until use. The slides were rotated (64 rpm) at 4°C for 30 minutes before the cells were gently tipped off of the slide and the slides were placed vertically in 2.4% gluteraldehyde-PBS fixative ovemight at 4°C. In some cases, mouse lymphocytes were treated with MEL-14 antibody for 10 minutes at 4°C before being added to tissue sections. The number of lymphocytes bound per HEV was quantitated, and data are expressed as the mean number of cells bound per HEV of 36 HEV examined per each group.
Intravital microscopic experiments were done as described&; mice were anesthetized with ketamin (Ketavet; Parke-Davis, Munich, Germany; 80 mg/kg intraperitoneally [ip]) after premedication with pentobarbital (Nembutal; Sanofi, Hannover, Germany; 20 mgkg ip) and atropine (0.1 mg/kg ip). The mice were thermocontrolled and received an intravenous (IV) infusion as to maintain anesthesia and a neutral fluid balance.
The cremaster muscle was prepared for intravital microscopy as described. 44 The surgical procedure took -10 minutes. Throughout the experiment muscle was superfused with thermocontrolled (37°C) bicarbonate-buffered saline. The animals breathed spontaneously through a tracheal tube. Leukocyte rolling was observed in venules (diameter 17 to 69 pm) for -90 seconds each using intravital microscopy, and video recordings were made through a multidiode camera on a Panasonic S-VHS recorder (Panasonic, Osaka, Japan). Microvascular centerline red blood cell velocity was measured using a dual photodiode and an automatic tracking correlator. Centerline velocities were converted to mean blood flow velocities by multiplication with an empirical factor of 0.625 as described earlier.
Throughout the experiment, small 20-pL blood samples were withdrawn from the carotid catheter at -45-minute intervals and analyzed for leukocyte concentration after detergent lysis of erythrocytes using a hemocytometer. Additional samples were taken after administration of MoAb and at the end of each experiment. Differential
Stamper-Woodrufl test.
In Vivo leukocyte rolling.
leukocyte counts were obtained by microscopy of Giemsa-stained blood smears. Microvessel diameter was measured interactively using a digital image processing system. and rolling leukocyte flux was determined by counting the number of leukocytes passing each venule as described. Total leukocyte flux was estimated as the product of measured systemic leukocyte concentration and blood volume flow. Microvessel blood flow was calculated using the circular cross-sectional area multiplied with mean blood flow velocity. Leukocyte rolling flux fraction is defined as the flux of rolling leukocytes in percent of total leukocyte flux. By way of its definition, leukocyte rolling flux fraction is independent of variations of systemic leukocyte counts.
Leukocyte rolling in different experimental groups was compared using Student's t-test and Bonferroni correction for multiple comparisons where appropriate.
The in vivo migration of lymphocytes was analyzed as described. 45 Lymphocytes from PLN and MLN from six C57BW6J mice were obtained and labeled with 50 yCi of 5'chromium/mL in DMEM containing 2% FCS. After incubation of these samples at 37°C for 1 hour, cells were overlayed on 3 mL of FCS and centrifuged. After washing with ice-cold DMEM, cells were preincubated for 15 minutes at room temperature in 1.8 mL of DMEM with/witbout MEL-14 MoAb. A total of 3 x 10' lymphocytes in 0.2 mL were injected into tail veins of 8 to IO-week-old CD34-deficient or wild-type mice. Each group consisted of four mice each. Mice were killed 1 hour and 24 hours after injection, and the distribution of radioactivity in different organs was measured.
Peritonitis was induced by injecting 1 mL of 3% thioglycollate (DIFCO, Detroit, MI) into the peritoneal cavity. After various times, mice were killed and peritoneal cells were obtained by injecting 5 mL of PBS and removing the injected liquid. Cells in the peritoneal lavage were counted using a hemocytometer. The number of neutrophils in the samples was determined by the smears stained with Wright-Giemsa stain and differentially counted. In some animals, blood was c olected from cardiac punctures at the time of death and leukocyte counts were determined as described above.
Sheep red blood cells (SRBC), stored in Alsever's solution at 4"C, were washed three times in PBS before use. Mice were immunized subcutaneously (sc) in the shaved back with 2 X IO5 SRBC in a volume of 50 yL PBS. The mice were challenged on day 5 after the initial sensitization by injecting 1 x 10' SRBC in a volume of 50 pL PBS sc into the right hind footpad. PBS (50 yL) was also injected into the left hind footpad as a control. Footpad thickness was measured in both feet at the same relative location using a constant force, calibrated digital thickness gage (Mitsutoyo Corp, Tokyo, Japan).
Eosirzophit accumulation assay by OVA. Mice were sensitized by ip injection of OVA (0.1 mg in 500 pL of PBS per mouse) on day 1 of treatment. On day 8, animals were challenged by exposure to aerosolized antigen (2% OVA for 5 minutes) using a Whisper Jet Nebulizer system (MMP, Englewood, CO). Daily from days 15 to 21, mice were challenged by exposure to aerosolized antigen (1% OVA for 20 minutes, every 12 hours). In each experiment, we used 6 +/+ and 6 -/-mice and inhalated them in the same cage. The experiment was repeated three times. Lung samples were obtained 3 hours after last inhalation. Lung samples were fixed in 10% formalin for hematoxylideosin (H&E) staining or Giemsa staining. To confirm the identity of eosinophils we also performed DAB staining. Lung sections were presoaked in normal saline for 15 minutes and preincubated for 10 minutes at room temperature in 5 mg 3,3-diaminobenzidine (DAB; Sigma) dissolved in I O mL 0.05 mom Tris buffer (pH 7.6) (longer incubation times result in the detection of neutrophils as well). One-tenth milliliter of 1% Hz02 was added to DAB-Tris solution and incubated for 20 minutes at room temperaLeukocyte homing tesr.
Migration of neutrophils into the peritoneal cavity.
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For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From Immunohistochemistry for CD4 and CD8 cells was also performed. The number of the inflammatory cells including eosinophils and lymphocytes in sections from perivascular areas were examined. We counted a total of at least 1, OOO inflammatory cells per sagital section, which included every lobe of the lung.
In vitro colony-forming assay and spleen colony assay. Methylcellulose culture was performed using a modification of the technique as previously described." One milliliter of culture medium contained an appropriate number of cells, 1.2% methylcellulose (Fisher Scientific, Norcross, GA), @-medium (GIBCO), 30% FCS (GIBCO), 1% deionized bovine serum albumin (BSA; Sigma), 0.1 mmom 2ME, and various cytokines as described in text. The final concentrations used in this experiment are 20 ng/mL recombinant mouse stem cell factor (rmSCF; Genzyme, Cambridge, MA), 2.5 ng/mL recombinant murine IL-3 (rmIL-3; Genzyme) and 2 U/mL recombinant human erythropoietin (rhEpo; Amgen, Thousand Oaks, CA). The mixture was incubated in 35-nun nontissue culture dishes (Lux; Miles Scientific, Naperville, IL) under a humidified 5% CO, atmosphere at 37°C. The number of colonies were scored after 7 days of culture for CFU-GM and 10 days for BFU-E and 14 days for CFU-GEMM using an inverted microscope.
The spleen colony assay (CFU-S day 12 assay) was performed as previously described." BM cells from femurs were injected into lethally irradiated mice (10 Gy total body irradiation) from a dual '37Cs source at a dose of 1.0 Gy/min. The spleens were removed on days 12 after transplantation, fixed in Bouin's solution, and macroscopically visible spleen colonies were counted.
In vivo 5-jluorouracil (5FU) administration. 5-FU (150 mgkg) was administered into the tail vein of four wild-type and four mutant mice. Seven days after administration BM cells were collected and cultured in in vitro colony assays in the presence of IL-3, SCF, and Epo. The number of CFU-GM colonies were counted 7 days after plating. Peripheral white blood cells (WBCs) were counted 2 and 7 days after administration of 5FU.
In vivo granulocyte colony-stimulating factor (G-CSF) administrarion. rh G-CSF (Amgen) was administered into five wild-type and five mutant mice using sc-implanted osmotic pumps, which produced G-CSF at 200 pg/kg/d for 5 days. Peripheral blood, spleen, and BM cells were collected and suspensions prepared. Nucleated cells from BM, spleen, and peripheral blood were used for in vitro colony assays in the presence ILL-3, SCF, and Epo as growth factors (see Fig 11) .
OP-9 is a stromal cell line which was established from newbom calvaria of the (C57BW6 X C3H) F2-op/op mouse that lacks functional M-CSF because of a mutation in the M-CSF gene. 48 The OP-9 cell line was cultured to confluence in 24-well plates (Costar, Cambridge, MA). Two thousand Lin-Kit+ cells sorted from wild-type and CD34-deficient murine BM cells were cultured on this stromal cell layer with 1.0 mL of a-medium containing 10% FCS. After coculture for 2 weeks, nonadherent and adherent cells were procured and served for colony assay with IL-3 and Epo.
Coculture of sorted progenitors with stromal cells.
RESULTS

Targetting the CD34 gene and generation of mutant mice.
CD34 is a type I integral membrane protein." Its cytoplasmic tail is phosphorylated by activated protein kinase C both in mice and human^.'^.^^ Murine and human coding sequences are highly similar": cytoplasmic domains are greater than 90% identical and contain several potential phosphorylation sites for protein kinases. The construct used for targeted disruption of the CD34 gene, pTINeo3.2, contains 3.9 kb of homologous CD34 genonic DNA and a deletion of 0.72 kb into which the neo-mycin resistance (neol) gene has been introduced in an antisense orientation (Fig IA) . The deletion (amino acids 270-326) removes exons encoding the entire transmembrane region. Furthermore, because there are stop codons in-frame in the inserted antisense neo gene, protein sequences beyond the beginning of exon 7 are not expected to be translated. Using this construct we produced homozygous mice from intercrossing heterozygous mutants. The mutated CD34 gene was confirmed by genomic Southern blot analysis of tail DNA (Fig 1B) .
Mutant heterozygous and homozygous mice showed no apparent differences in size, behavior, or reproductive ability as compared with wild-type littermates. Life spans of mutant mice also appeared to be normal (observed up to 80 weeks). Gross examination of internal organs also showed no abnormality in mutant mice, and interbreeding of heterozygous mice generated expected mendelian 1 :2: 1 ratios.
The expression of CD34 in hematopoietic stem cells from wild-type and homozygous mutant mice was analyzed. Freshly isolated BM cells were stained with anti-CD34 polyclonal antibody (1202)" Sca-1 or anti-kit MoAb, in addition to staining with antibodies to lineage (Lin) markers (TER-119, B220, Mac-1, Gr-1, CD4, and CD8). Wild-type mice expressed CD34 in Sca-1'Lin- (Fig 2) or Kit+Lin-fractions (data not shown). In contrast, specific staining as expected was deficient in these fractions from homozygous mice. However, percentages of Sca-l+Lin-and Kit+Lin-fractions in BM was the same in both groups, as was the percentage of LFA-1, ICAM-I, VLA-4, VLA-5, CD43, and CD44-positive staining in BM cells (data not shown).
The expression of CD34 on endothelial venules PLN was analyzed by immunohistochemistry using antimouse CD34 MoAb (RAM34; Pharmingen). There was clear CD34 staining of HEV from PLN of wild-type mice, whereas no staining was evident in homozygous mice (Fig 3) .
CD34 was found in PLN HEV lysate analyzed by Western blots using MECA-79 MoAb. The top portion, but not all of the 90-kD band, was absent in CD34-deficient mice ( Fig  4A) . To further investigate this observation, we precleared C57BU6J lymph node lysate using anti-CD34 MoAb-bound agarose before electrophoresis. As expected, the top half of the 90-kD species of PNAd was removed (Fig 4B, lane 3) , and this species reappeared when we eluted protein from the anti-CD34 MoAb-bound agarose (Fig 4B, lane 7) . These results show that the 90-kD band is representative of other protein(s) besides CD34. They also confirm that CD34 expression was absent in our mice.
Attachment of lymphocytes to HEV in the peripheral lymph nodes of CD34-dejcient mice in vitro. Adhesion of splenocytes isolated from control C57BL/6J mice to HEV in the PLNs from CD34 wild-type or deficient mice was assessed using the in vitro Stamper-Woodruff assay. Lymphocytes from control mice bound with high efficiency to PLN HEV from both CD34-deficient and wild-type mice (Fig 5) . In both groups, lymphocyte binding was reduced by 98% by treatment with MEL-14 MoAb. Lymphocyte binding in both groups was, thcrefore, L-selectin dependent. Leukocyte rolling can be observed in the venules of cremaster muscle Loss of CD34 expression in mutant mice.
Leukocyte rolling in CD34-dejicient mice.
For personal use only. For personal use only. on August 30, 2017. by guest www.bloodjournal.org From Fig 2. CD34 cell-surface expression by purified progenitor cells from wild-type mice ( + I + ) and CD34-deficient mice (-/-). EM cells were stained with antimouse-rabbit CD34 polyclonal antibody (1202"). followed by fluorescein isothiocyanate (FITCI-conjugated goat-antirabbit lg antibody (Boehringer Mannheim). After that they were stained with phycoerythrin IPE)-conjugated antimouse CD4, CD8, 8220, Gr-1, Mac-1, TER-119, and biotin-conjugated antimouse Scal, followed by Streptoavidin-Red 613 (GIECO). CD34 expression in the Scal' Lin-fraction from these mice was indicated.
of anesthetized mice using intravital microscopy." The ability of leukocytes to roll along the endothelial lining of venules in cremaster muscle in three homozygote and three wild-type mice was examined to determine the possible function of CD34 adhesion during inflammatory processes. The only inflammatory stimulus was the exteriorization of the tissues for observation.
In cremaster muscle of wild-type mice we investigated leukocyte rolling in 26 venules. which had diameters in the range of 18 to 62 pm (30 I 2 p m ) and RBC velocities between 0.85 and 6.0 mm/s (2.3 -C 0.3 mm/s). During the first 90 minutes after surgical exposure of the muscle, rolling leukocyte flux averaged 46% t 5% of all passing leukocytes (range. 1 1 % to 92%). This meant that on average, 46% of all leukocytes passing through the venules interacted with the endothelium. We measured leukocyte rolling in CD34-deficient mice using 28 hemodynamically similar venules. Mean vessel diameter ranged from 19 to 64 pm (31 2 2 pm). and velocities were between 0.8 and 4.4 mm/s (2.5 2 0.2 mm/s). The rolling leukocyte flux fraction was 46% 2 5% (range 6% to 98%) in these mutant mice. showing no difference from wild-type. MoAb treatment was also examined in both of these mice. Each bar represents mean (+SEMI number of cells bound per HEV, of 36 HEV examined per each group. * P < .02; **P e .Ol. MoAb at a dose of 80 pg per mouse. In both wild type mice and CD34-deficient animals rolling was drastically reduced by MEL-14, to 14% 2 4% in wild-type mice and 6% 2 2% in CD34-deficient mice (Fig 6A) .
In previous experiments with L-selectin-deficient mice, leukocyte rolling flux was seen to decrease significantly at time points between 30 and 60 minutes compared with wildtype mice." Therefore, the time course of leukocyte rolling in CD34 mutant mice was assessed (Fig 6B) . No differences in the rolling flux were found at different time points.
In vivo lymphocyte homing in CD34-dejcient mice. TO determine the effects of CD34 deficiency on lymphocyte migration in vivo, splenocytes from control CS7BL/6J mice were isolated, labeled with "Cr, and injected IV into CD34-deficient mice and wild-type mice. Mice were killed 1 or 24 hours after injection and radioactivity in various organs measured using the gamma counter. At 1 hour (Fig 7A) and 24 hours (Fig 7B) , the accumulations of radiolabeled cells in the PLN, MLN, Peyer's patch (PP) and spleen was similar for CD34-deficient and wild-type mice. In addition, administration of MEL14 MoAb into both CD34-deficient and wildtype dramatically reduced lymphocyte homing in PLNs. Similar reductions were seen in mutant mice as with wildtype controls.
The impact of the CD34 mutation on acute inflammatory responses was assessed using thioglycollate, which effectively induces neutrophil-mediated inflammation." Thioglycollate was injected into the peritoneal cavity of CD34-deficient mice and wild-type mice. The accumulation of neutrophils in the peri-
Neutrophil migration in CD34-dejcient mice.
For toneal cavity was measured 2,4, and 6 hours after the administration. As shown in Fig 8, there were no differences in total number of neutrophils in the peritoneal exudates between CD34-deficient mice and wild-type mice. Also, there were no significant differences between CD34-deficient and wild-type mice in the number of peripheral leukocytes after thioglycollate injection (data not shown).
3557
Dchyerl-type hyl'er.~er?sitil.in.. Mice were sensitized by sc injection of SRRC and challenged after S days with SRRC in the footpad. Swelling was measured in challenged footpads and compared with control pads. Pads increased in thickness by 73% 2 4% and 24% ? 3% in wild-type and CD34-deficient mice, respectively. at 24 hours after challenge. indicating that CD34 was not required for delayed type hypersensitivity by SRBC.
Eosirlophil rrcctonrrlatinrl in the I I I I I~~ after OVA i~~h a l r r i o r z .
Eosinophil accumulation was observed mainly in perivascular areas. There was also some accumulation in parenchymal areas. In wild-type mice killed 3 hours after last inhalation (peak eosinophil accumulation 3 to 4 hours after last inhalation was observed in preliminary experiments). accumulation was about threefold lower in CD34 mutants (Fig 9) . Furthermore. eosiniphil numbers were decreased in broncheal alveolar lavage (BAL) of mutant as compared with controls (data not shown). The number of CD4 and CD8 T cells appeared to be reduced in sections from mutant mice. although the
. ., ., ., ., . , ., For Hours after injection between CD34 mutant mice and wild-type. Moreover. in the presence of stem cell factor, IL-3 and Epo. BM cells from mutant mice produced normal numbers of progenitor cells (CFU-GEMM. CFU-GM) in vitro. In addition, the CFU-S day 12 in spleens of irradiated C57BLI6J mice reconstituted with BM cells from either mutant or wild-type donors showed no differences (Fig 10A) . Moreover, the total number of cells in spleen or thymus were normal, and the number of CFU-GM, CFU-GEMM. and CFU-S day I2 in the spleen showed no differences between these mice (Fig IOB) . normal in mutant animals. Peripheral WBCs after G-CSF administration was 31.250 t-18.544 and 23.500 +-5.076 in wild-type and mutant mice, respectively. CFU-GM markedly increased in peripheral blood and spleen after G-CSF administration both in mutant and wild-type mice. whereas no significant differences were seen in CFU-GM in peripheral blood, spleen. or BM between these mice (Fig I 1 ) . Administration of 5FU showed no differences in peripheral WBC counts after day 2 and day 7. and total number of' CFU-GM 7 days after administration was also normal ( Table l ) . 1r~terrrctiorl.s hctweerl stern cells (Incl strorm cells. To investigate interactions between CD34-deficient stem cells and stromal cells. we used fluorescent-activated cell sorter to enrich progenitor cells from mutant and wild-type mice. Two thousand kit'Lin.. cells were cocultured with OP-9. an M-CSF-defective stroma cell line. and the total number of colonies were determined after 14 days. The number of progenitor cells after coculture was not impaired in CD34-deficient mice (+/+ 10.9 t-9.5; -/-15.0 t 13.9). Also. emperiporesis, as evidenced by a cobblestone appearance (which correlates with the production of mature granulocytic cells5"). was not affected in CD34-deficient mice (Fig 12) . This indicated normal stromal cell-stem cell interactions.
DISCUSSION
In addition to its expression on hematopoietic stem cells.51 CD34 is found on BM stroma" and vascular endothelium."
In vitro binding experiments with CD34 have shown that it hinds L-selectin IgG chimeric protein. L-selectin. in turn. is known to mediate lymphocyte homing to PLN.'" play a role in the trafficking of neutrophils to acute areas of inflammamicroscopy."".5" All of these functions are defective in Lselectin-deficient mice."." These data suggested that CD34-tion*57-??
and be involved in late phase rolling in intravital 3559 deficient mice may have a defect in leukocyte trafficking. We analyzed various trafficking-related functions in the mutant mice and found no impairment in the binding of lymphocytes to HEV preparations in vitro (Fig S) . leukocyte rolling (Fig 6A and B) . and extravasation to the peritoneum (Fig 8) was normal. a s was lymphocyte homing (Fig 7A and B) In contrast, howcver. eosinophil accumulation in the lung after OVA treatment was significantly reduced in mutant mice. CD4' T cells are important for eosinophil accumulation in this model." Interestingly. there were no significant differences in the observed numbers of CD4' cells in the lungs of mutant animals compared with wild-type controls. despite markedly reduced eosinophilia in mutant animals. Also the numbers of eosinophils in BAL are reduced in CD34-deficient mice. Preliminary data suggest that IL-5. previously reported a s a potent eosinophil chemoattractant. showed no significant differences in levels found in BAL fluid and serum between normal and mutant mice. I t remains unclear why the lungs of mutant mice exhibited reduced eosinophil infiltration after exposure to allergen. In humans. the anti-L-selectin MoAb LAMI-I I has been shown to selectively inhibit (in an epitope-specific manner) eosinophil attachment to endothelial cells in vitro."' According to this report. CD34 may be the counterpart of this specific epitope on the L-selectin of eosinophils. We are now examining the expression of various chemokines in the lung, and are also checking for eosinophil accumulation using other models, such as after inhalation of chemoattractant or injection into peritoneum or skin.
Polyclonal anti-CD34 antibody, L-selectin IgG chimera," and MECA-79?%' react with 90-kD glycoprotein isolated from PLN. Performing Western blot analysis on PLN lysate from mutant mice showed a residual 90-kD band. As a result we performed a series of Western blots using lysate from wild-type mice and discovered that the 90-kD band actually consisted of at least two different proteins, and only one of them exhibited reactivity with CD34 MoAb. This was confirmed by preclearing wild-type PLN lysates with antirat IgG sepharose beads preloaded with antLCD34 MoAb. removing the upper portion of the 90-kD species that reappeared after elution. Thus. the 90-kD MECA-79 band comprises at least two species-CD34 and an independent species which migrates with only a slight different rate during PAGE. Although the 200-kD protein remains as a possible ligand for L-selectin-mediated leukocyte trafficking, we found a 90-kD band that contains an additional candidate ligand(s).
Leukocyte development and distribution was generally normal in CD34-deficient mice, despite the expectation that CD34 played a role in early hematopoie~is.'~~" Total numbers of cells in BM, spleen, thymus, or peripheral blood, and also progenitors in BM and spleen were normal. We could see no differences in progenitor cell numbers after 5FU and G-CSF treatment. Also, mobilization assays using not only G-CSF, but also GM-CSF, megakaryocyte growth and development factor (MGDF), G-CSF + SCF, and G-CSF + FLT-3 ligand showed no defects in CFU-GM, CFU-GEMM, BFU-E, and CFU-Meg homeostasis in mutant mice (data not shown). Moreover, we anticipated involvement of CD34 in interactions between stem cells and stromal cells.
However, progenitor cells (kit'Lin-) from wild-type and mutant mice cocultured with OP-9 BM stromal cell line grew similarly and appeared to interact normally. We investigated whether alternative ligands may have been unpregulated to compensate for a loss of CD34 expression, and which may have resulted in normal interactions between stromal and stem cells. The expression of LFA-1, ICAM-I . and VLA-4, VLA-5. CD44, and CD43 in BM cells from mutant and control mice showed no differences (data not shown).
In conclusion, eosinophil accumulation in the lung after OVA inhalation is reduced in CD34-deficient mice. However, CD34 does not appear to be an indispensable ligand for L-selectin-mediated lymphocyte and neutrophil trafficking and hematopoiesis, at least in adult mice. Cloning of the other species which make up the PNAd, such as the 90-kD and 200-kD species, will be helpful in elucidating the mechanisms of L-selectin-mediated leukocyte trafficking. Our finding that an additional 90-kD species exists that is crossreactive with the MECA-79 MoAb highlights the possibility that other, as yet uncharacterized, molecule(s) may be involved in leukocyte trafficking.
